IGC Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of IGC Pharma using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-11-17 | $-0.02 | $-0.02 | 0.00 % |
| Q1 | 2025-08-14 | $-0.02 | $-0.03 | 33.3 % |
| Q4 | 2025-06-27 | $-0.01 | $-0.02 | 50.0 % |
| Q3 | 2025-02-18 | $-0.02 | $-0.03 | 33.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-11-17 | $191.00K | $353.80K | -46.0 % |
| Q1 | 2025-08-14 | $328.00K | $327.60K | 0.12 % |
| Q4 | 2025-06-27 | $330.00K | $305.00K | 8.20 % |
| Q3 | 2025-02-18 | $257.00K | $204.00K | 26.0 % |
IGC Pharma (IGC) is scheduled to report earnings on February 17, 2026. The last reported earnings were for reported on November 17, 2025 for Q2.
The Actual EPS was $-0.02, which hit the estimate of $-0.02.
The Actual Revenue was $191K, which missed the estimate of $353.8K.
Browse earnings estimates, EPS, and revenue on all stocks.